4.7 Review

Patient-derived xenograft (PDX) models, applications and challenges in cancer research

Journal

JOURNAL OF TRANSLATIONAL MEDICINE
Volume 20, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s12967-022-03405-8

Keywords

Cancer animal model; PDX; Preclinical study; Humanized model; Avatar model of cancer

Ask authors/readers for more resources

The establishment and application of patient-derived xenograft models have played a significant role in cancer treatment. These models accurately represent the biological characteristics of different cancers and have great value in the development of anti-cancer drugs and personalized medicine.
The establishing of the first cancer models created a new perspective on the identification and evaluation of new anti-cancer therapies in preclinical studies. Patient-derived xenograft models are created by tumor tissue engraftment. These models accurately represent the biology and heterogeneity of different cancers and recapitulate tumor microenvironment. These features have made it a reliable model along with the development of humanized models. Therefore, they are used in many studies, such as the development of anti-cancer drugs, co-clinical trials, personalized medicine, immunotherapy, and PDX biobanks. This review summarizes patient-derived xenograft models development procedures, drug development applications in various cancers, challenges and limitations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available